Anish R. Mitra

Anish R. Mitra

Auto-generated profile, based on publicly available information

Anish R. Mitra

Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
RHRyan L. Hoiland
Ryan L. Hoiland
NFNicholas A. Fergusson
Nicholas A. Fergusson
AMAnish R. Mitra
Anish R. Mitra
DGDonald Griesdale
Donald Griesdale
DDDana V. Devine
Dana V. Devine
MSMypinder Sekhon
Mypinder Sekhon
Studies on severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) suggest a protective effect of anti-A antibodies against viral cell entry that may hold relevance for SARS-CoV-2 infection. Therefore, we aimed to determine whether ABO blood groups are associated with different severities of COVID-19. We conducted a multicenter retrospective analysis and nested prospective observational substudy of critically ill patients with COVID-19. We collected data pertaining to age, sex, comorbidities, dates of symptom onset, hospital admission, intensive care unit (ICU) admission, mechanical ventilation, continuous renal replacement therapy (CRRT), standard laboratory parameters, and serum inflammatory cytokines. National (N = 398 671; P = .38) and provincial (n = 62 246; P = .60) ABO blood group distributions did not differ from our cohort (n = 95). A higher proportion of COVID-19 patients with blood group A or AB required mechanical ventilation (P = .02) and CRRT (P = .004) and had a longer ICU stay (P = .03) compared with patients with blood group O or B. Blood group A or AB also had an increased probability of requiring mechanical ventilation and CRRT after adjusting for age, sex, and presence of ≥1 comorbidity. Inflammatory cytokines did not differ between patients with blood group A or AB (n = 11) vs O or B (n = 14; P > .10 for all cytokines). Collectively, our data indicate that critically ill COVID-19 patients with blood group A or AB are at increased risk for requiring mechanical ventilation, CRRT, and prolonged ICU admission compared with patients with blood group O or B. Further work is needed to understand the underlying mechanisms.

27 May 2020 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
AMAnish R. Mitra
Anish R. Mitra
NFNicholas A. Fergusson
Nicholas A. Fergusson
ELElisa Lloyd-Smith
Elisa Lloyd-Smith
AWAndrew Wormsbecker
Andrew Wormsbecker
DFDenise Foster
Denise Foster
DGDonald Griesdale
Donald Griesdale
Background: Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with high intensive care unit (ICU) mortality. We aimed to describe the clinical characteristics and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) in a Canadian setting. Methods: We conducted a retrospective case series of critically ill patients with laboratory-confirmed SARS-CoV-2 infection consecutively admitted to 1 of 6 ICUs in Metro Vancouver, British Columbia, Canada, between Feb. 21 and Apr. 14, 2020. Demographic, management and outcome data were collected by review of patient charts and electronic medical records. Results: Between Feb. 21 and Apr. 14, 2020, 117 patients were admitted to the ICU with a confirmed diagnosis of COVID-19. The median age was 69 (interquartile range [IQR] 60–75) years, and 38 (32.5%) were female. At least 1 comorbidity was present in 86 (73.5%) patients. Invasive mechanical ventilation was required in 74 (63.2%) patients. The duration of mechanical ventilation was 13.5 (IQR 8–22) days overall and 11 (IQR 6–16) days for patients successfully discharged from the ICU. Tocilizumab was administered to 4 patients and hydroxychloroquine to 1 patient. As of May 5, 2020, a total of 18 (15.4%) patients had died, 12 (10.3%) remained in the ICU, 16 (13.7%) were discharged from the ICU but remained in hospital, and 71 (60.7%) were discharged home. Interpretation: In our setting, mortality in critically ill patients with COVID-19 admitted to the ICU was lower than in previously published studies. These data suggest that the prognosis associated with critical illness due to COVID-19 may not be as poor as previously reported.

23 May 2019 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
CMChristopher Ma
Christopher Ma
JLJeffrey K. Lee
Jeffrey K. Lee
AMAnish R. Mitra
Anish R. Mitra
ATAnouar Teriaky
Anouar Teriaky
DCDaksh Choudhary
Daksh Choudhary
VJVipul Jairath
Vipul Jairath
Summary: Background: Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment of inflammatory bowel disease.Aims: To determine the efficacy and safety of JAK inhibitors compared to placebo for the treatment of Crohn's disease (CD) and ulcerative colitis (UC).Methods: PubMed, Embase and CENTRAL were systematically searched to November 1, 2018. Randomised placebo‐controlled trials (RCTs) of JAK inhibitors in adult patients with CD or UC were eligible. Open‐label extension studies without a placebo comparator arm were excluded. Clinical, endoscopic, and safety outcomes were extracted and rates relative to placebo were pooled using a random‐effects model.Results: A total of 12 RCTs (5 CD, 7 UC) were included. Patients were randomised to placebo (n = 844), tofacitinib (n = 1882), filgotinib (n = 130), peficitinib (n = 176), upadacitinib (n = 387) or TD‐1473 (n = 31). JAK inhibitor treatment was associated with induction of clinical remission in CD (RR, relative risk 1.38 [95% confidence interval CI 1.04‐1.83], P = 0.025, I2 = 14%) and UC (RR 3.07 [95% CI 2.03‐4.63], P < 0.001, I2 = 0%). In UC, JAK inhibitor treatment was associated with induction of endoscopic remission (endoscopic Mayo subscore MCSe = 0/1) (RR 2.43 [95% CI 1.64‐3.59], P < 0.001, I2 = 27%) and mucosal healing (MCSe = 0) (RR 5.50 [95% CI 2.46‐12.32], P < 0.001, I2 = 0%). JAK inhibitor treatment increased the risk of infection compared to placebo (RR 1.40 [95% CI 1.18‐1.67], P < 0.001, I2 = 0%), particularly for herpes zoster.Conclusions: JAK inhibitors are effective for inducing clinical remission in CD and induction of clinical and endoscopic remission in UC, although are associated with an increased risk of infectious complications.

31 March 2020 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
ATAdam Thomas
Adam Thomas
GHGreg Haljan
Greg Haljan
AMAnish Mitra
Anish Mitra

1 May 2010 in Neuropsychologia
Verified
Journal Article
Closed access
AMAnish R. Mitra
Anish R. Mitra
MAMathias Abegg
Mathias Abegg
JVJayalakshmi Viswanathan
Jayalakshmi Viswanathan
JBJason J.S. Barton
Jason J.S. Barton

30 October 2013 in Pediatric Neurosurgery
Verified
Journal Article
Closed access
PDF file
ASAsh Singhal
Ash Singhal
AMAnish Mitra
Anish Mitra
DCDoug Cochrane
Doug Cochrane
PSPaul Steinbok
Paul Steinbok
Background/Aims: Lumbar disc herniation (LDH) can be associated with ring apophysis fracture (RAF), which is found in 6% of adult cases. However, the incidence and management of RAF in pediatric LDH is not well documented. The purpose of this study is to determine the prevalence of RAF in pediatric LDH, identify risk factors and explore the influence of RAF on the surgical management and outcome of LDH patients. Methods: Hospital records and images were retrospectively reviewed for all pediatric patients (<18 years old) who underwent CT scanning for LDH at BC Children's Hospital from 1985 to 2010. Results: Forty-two patients met the study inclusion criteria. RAF was present in 38% of the pediatric patients with LDH. There was a significant correlation with gender (p = 0.021; 55% of the males had RAF, and 20% of the females) and association with central herniations (p = 0.003). At the last follow-up, 58% of the patients with RAF were symptom free, compared with 68% of the patients with no RAF. Conclusion: RAF is more frequently associated with LDH in children than in adults. Gender and central disc herniation are associated with RAF. Given the frequency of RAF, to properly identify these fractures and anticipate their treatment, preoperative CT would be necessary.